Healthequity, INC Form 4 insider transactions

HealthEquity's EVP and Chief Technology Officer, Elimelech Rosner, reported a disposition of 2,982 shares of common stock to cover tax withholding obligations at a price of $100.8721 per share.

HealthEquity's EVP, Chief Commercial Officer, Michael Henry Fiore, reported the disposition of 1,636 shares for tax withholding and the sale of 1,794 common shares, all executed under a Rule 10b5-1 trading plan.

HealthEquity, Inc. Director Evelyn S. Dilsaver reported the acquisition of 2,003 restricted stock units and detailed her existing stock option holdings, pursuant to a Rule 10b5-1 plan.

HealthEquity, Inc. Director Robert W. Selander has acquired 2,003 restricted stock units, increasing his direct beneficial ownership to 86,972 shares.

HealthEquity, Inc. Director Adrian T. Dillon acquired 2,003 shares of common stock through a restricted stock unit grant, increasing his total beneficial ownership to 59,518 shares.

HealthEquity, Inc. Director Gayle Furgurson Wellborn acquired 2,003 shares of common stock through restricted stock units, increasing her direct beneficial ownership to 19,733 shares.

HealthEquity, Inc. Director Debra McCowan acquired 2,003 shares of common stock through a restricted stock unit grant on June 26, 2025, increasing her total beneficial ownership to 9,782 shares.

HealthEquity, Inc. Director Rajesh Natarajan has acquired 2,003 restricted stock units, increasing his direct beneficial ownership to 14,277 shares of common stock.

HealthEquity, Inc. Director Stuart B. Parker was granted 2,003 restricted stock units, increasing his total beneficial ownership to 21,835 common shares.

Former HealthEquity, Inc. director Jon Kessler reported exercising stock options and subsequently selling a significant number of common shares, both directly and indirectly through GKF, LLC, on June 6, 2025.

HealthEquity's Executive Vice President and Chief Technology Officer, Elimelech Rosner, sold 71,000 shares of common stock for approximately $7.98 million in early June 2025, pursuant to a Rule 10b5-1 trading plan.

Robert W. Selander, a director at HealthEquity, Inc., executed stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reported disposing of 9,019 shares of common stock on April 8, 2025, to cover tax obligations.

Delano Ladd, EVP and General Counsel of HealthEquity, Inc., reported the disposal of 6,991 shares of common stock on April 8, 2025.

Director Jon Kessler reports disposition of HealthEquity stock to cover tax obligations, while maintaining significant holdings.

Elimelech Rosner, EVP, CHIEF TECHNOLOGY OFFICER of HealthEquity, Inc., reports the disposal of 52,078 shares of common stock to cover tax obligations.

Michael Fiore, EVP and Chief Commercial Officer of HealthEquity, Inc., sold 8,881 shares of common stock at a price of $78.2621 per share on April 4, 2025, under a pre-arranged 10b5-1 trading plan.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reports transactions involving common stock and restricted stock units, resulting in changes to his beneficial ownership.

Director Jon Kessler reports acquisition and disposal of HealthEquity, Inc. common stock and holdings of derivative securities.

EVP and Chief Commercial Officer of HealthEquity, Michael Fiore, reports acquisition and disposal of company stock.

EVP and Chief Technology Officer of HealthEquity, Elimelech Rosner, reports acquisition and disposal of common stock and restricted stock units.

James Lucania, EVP & CFO of HealthEquity, Inc., reported the acquisition and disposal of company stock on April 2nd and 3rd, 2025.

Delano Ladd, EVP and General Counsel of HealthEquity, Inc., reports the acquisition and disposal of company stock and derivative securities.

Scott Cutler, CEO of HealthEquity, Inc., reports the acquisition and disposal of common stock and restricted stock units.

Delano Ladd, EVP and General Counsel of HealthEquity, Inc., reported the disposal of 395 shares of common stock on April 1, 2025.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, reports the disposition of shares to cover tax obligations and discloses beneficial ownership of common stock and stock options.

Director Robert Selander exercised stock options and sold shares of HealthEquity, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Rajesh Natarajan, a director at HealthEquity, Inc., acquired 771 shares of common stock on February 3, 2025, through the vesting of restricted stock units.

Director Stuart B. Parker reports acquisition of 771 shares of HealthEquity, Inc. common stock through vesting of restricted stock units.

HealthEquity's EVP, Chief Technology Officer, Elimelech Rosner, sold 1,707 shares of common stock to cover tax obligations.